These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012

Jan 17, 2017
"Reinforcing the Efficacy of Immunotherapy for the maintenance of remission in AML with Ceplene®", February 20, 2017
Jan 9, 2017
Nov 22, 2016
Confirms plans for pivotal phase 3 Overall Survival study with Ceplene in AML
Nov 17, 2016
Oct 27, 2016
 

print email rss